Brokerages Set Avantor, Inc. (NYSE:AVTR) Target Price at $18.88

Shares of Avantor, Inc. (NYSE:AVTR - Get Free Report) have been given an average recommendation of "Hold" by the thirteen ratings firms that are covering the firm, Marketbeat Ratings reports. Seven research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $18.88.

Several analysts recently commented on AVTR shares. Robert W. Baird cut their target price on shares of Avantor from $21.00 to $17.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Cowen lowered shares of Avantor from a "buy" rating to a "hold" rating in a research note on Monday, April 28th. Raymond James reissued an "outperform" rating and set a $24.00 target price (down from $26.00) on shares of Avantor in a research note on Monday, February 10th. Citigroup cut their target price on shares of Avantor from $22.00 to $18.00 and set a "neutral" rating for the company in a research note on Tuesday, March 4th. Finally, Morgan Stanley lowered shares of Avantor from an "overweight" rating to an "equal weight" rating in a research note on Tuesday, April 29th.

Insider Activity at Avantor

In other Avantor news, EVP James Bramwell sold 3,758 shares of the company's stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $65,877.74. Following the transaction, the executive vice president now owns 87,379 shares in the company, valued at approximately $1,531,753.87. This represents a 4.12% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Gregory L. Summe acquired 25,000 shares of the company's stock in a transaction on Wednesday, May 7th. The stock was bought at an average price of $12.00 per share, for a total transaction of $300,000.00. Following the purchase, the director now owns 50,000 shares in the company, valued at approximately $600,000. This trade represents a 100.00% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders bought 53,100 shares of company stock worth $652,630. 1.20% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in AVTR. Rhumbline Advisers increased its stake in shares of Avantor by 1.8% during the 4th quarter. Rhumbline Advisers now owns 1,922,368 shares of the company's stock worth $40,504,000 after purchasing an additional 33,692 shares during the last quarter. Charles Schwab Investment Management Inc. increased its stake in shares of Avantor by 2.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,027,636 shares of the company's stock worth $63,792,000 after purchasing an additional 74,735 shares during the last quarter. Blue Trust Inc. increased its stake in shares of Avantor by 6.9% during the 4th quarter. Blue Trust Inc. now owns 8,069 shares of the company's stock worth $170,000 after purchasing an additional 522 shares during the last quarter. Robeco Institutional Asset Management B.V. increased its stake in shares of Avantor by 38.1% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 119,063 shares of the company's stock worth $2,509,000 after purchasing an additional 32,838 shares during the last quarter. Finally, Rhenman & Partners Asset Management AB increased its stake in shares of Avantor by 40.5% during the 4th quarter. Rhenman & Partners Asset Management AB now owns 61,826 shares of the company's stock worth $1,303,000 after purchasing an additional 17,826 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company's stock.

Avantor Price Performance

Shares of NYSE:AVTR traded up $0.46 during trading on Friday, reaching $13.15. The company had a trading volume of 13,271,512 shares, compared to its average volume of 7,933,383. The firm's fifty day moving average is $14.35 and its 200 day moving average is $18.15. The firm has a market capitalization of $8.96 billion, a PE ratio of 12.64, a price-to-earnings-growth ratio of 1.55 and a beta of 1.09. Avantor has a twelve month low of $11.82 and a twelve month high of $28.00. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.70 and a current ratio of 1.07.

Avantor (NYSE:AVTR - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $0.23 earnings per share for the quarter, hitting analysts' consensus estimates of $0.23. The company had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.61 billion. Avantor had a net margin of 10.49% and a return on equity of 12.17%. The business's revenue for the quarter was down 5.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.22 EPS. On average, equities analysts forecast that Avantor will post 1.06 EPS for the current year.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.